The Supreme Court today dismissed Bayer’s Special Leave Petition, pacing way for India’s first compulsory license for Bayer’s anticancer drug Nexavar.NATCO is now free to manufacture and sell a generic version of Nexavar (a kidney/liver cancer drug that goes by the generic name of Sorafenib Tosylate), but will have to pay a royalty on the net sales (every quarter) to Bayer.The...
